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Deer are acknowledged as hosts of Mycobacterium bovis, the causative agent of bovine tuberculosis (bTB), and
determining the prevalence of infection in deer species is one of the key steps in understanding the epidemi-
ological role played by cervids in the transmission and maintenance of bTB in the United Kingdom. This study
evaluated a rapid lateral-flow test for the detection of bTB in samples from wild deer species in the United
Kingdom. Fallow deer (Dama dama), roe deer (Capreolus capreolus), and red deer (Cervus elaphus) from areas
in Wales, the Cotswolds, and southwestern England were necropsied for a bTB survey. Serum samples from
individual deer were tested with the CervidTB STAT-PAK, and the results were evaluated against the culture
of M. bovis from tissues (n  432). Sensitivity and specificity were 85.7% (95% confidence interval [CI], 42.1
to 99.6%) and 94.8% (95% CI, 92.3 to 96.7%), respectively, with an odds ratio of 109.9 (95% CI, 12.7 to 953.6%)
for a positive STAT-PAK result among culture-positive deer. The low prevalence of infection (3.8%, n  860)
affected the confidence of the sensitivity estimate of the test, but all culture-positive fallow deer (n  6) were
detected by the test. In addition, antibodies to M. bovis could be detected in poor-quality serum samples. The
results suggest that the CervidTB STAT-PAK could be deployed as a field test for further evaluation.
In the United Kingdom, the involvement of wildlife species
in the disease dynamics of bovine tuberculosis (bTB) has fu-
eled research into their potential role in the maintenance and
transmission of the disease. Badgers (Meles meles) are thought
to be the main wildlife reservoir of bTB, but the presence of
Mycobacterium bovis in United Kingdom deer species (1, 4)
and the risk of spillover posed by deer in other countries (7, 18)
have driven the need to evaluate the risk posed to cattle by the
spillover of M. bovis from cervids in the United Kingdom.
A semiquantitative risk assessment indicated that fallow
deer (Dama dama dama) in particular posed a relatively high,
though localized, risk of transmission to cattle in areas with a
high incidence of bTB (5). However, model predictions were
constrained by the lack of adequate data on the abundance and
distribution of the six United Kingdom deer species and the
prevalence and distribution of M. bovis infection in these spe-
cies. To address this issue, the Department for the Environ-
ment, Food and Rural Affairs (DEFRA) commissioned addi-
tional surveys of M. bovis in deer (6).
Obtaining statistically robust prevalence estimates from
large wildlife populations poses a number of challenges, par-
ticularly when the prevalence of infection is low. In New Zea-
land, for example, control policies aimed at both domestic
(cattle and deer) and wildlife (possums) species have reduced
the herd prevalence of bTB in cattle and deer from 2.4% in
1993 to 0.35% in 2004 (21), but the assays used for whole-herd
diagnostic testing include an antibody enzyme-linked immu-
nosorbent assay and a lymphocyte transformation assay (9),
both of which require specialized laboratory equipment and
trained staff. The alternative is mycobacterial culture for the
diagnosis of M. bovis infection, and although this is the “gold
standard,” it is a labor-intensive, slow, and costly process which
cannot be performed animal side. The sensitivity of culture
depends on the thoroughness of the postmortem examination
(the range of tissue types and the quantity and area of each
tissue sampled), and it can take up to 12 weeks to obtain a
result.
The availability of accurate, more rapid, less labor-intensive,
and less expensive diagnostic assays which could be applied to
deer under field conditions would be of great advantage. Se-
rological assays, which are rapid and only require a blood
sample, obtainable from a single live sampling event, lend
themselves to the screening of large numbers of wild animals
(2). Changes to the antigen cocktails utilized for the detection
of specific antibody responses have improved sensitivity while
maintaining specificity (10), and STAT-PAK (Chembio Diag-
nostic Systems Inc., Medford, NY), a lateral-flow system for
the detection of immunoglobulin A (IgA), IgM, and IgG an-
tibodies to M. bovis and M. tuberculosis, has shown good po-
tential in a number of species (13, 14, 15), including badgers
(3). The STAT-PAK test format has also proven particularly
sensitive in detecting individuals with advanced disease caused
by M. bovis (13), and given that individuals with advanced
disease are also more likely to be excreting, they are important
targets for control programs. Chronically infected deer are
more likely to be skin test negative, and therefore antibody
tests play an important role in identifying these animals (9, 17).
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The CervidTB STAT-PAK, which utilizes a range of anti-
gens, including MPB83, ESAT-6, and CFP10, has been devel-
oped for the detection of antibodies to M. bovis and M. tuber-
culosis in deer. As an easy-to-use test which can be performed
in the field with only a small volume of blood, serum, or
plasma, the CervidTB STAT-PAK is potentially a valuable
alternative to mycobacterial culture and cell-based assays cur-
rently available for use in cervids (23). This study aimed to
evaluate the sensitivity, specificity, and accuracy of the
CervidTB STAT-PAK on serum from deer against the culture
of M. bovis from deer tissues obtained during DEFRA’s survey
of tuberculosis in deer in southwestern England and the
Cotswolds and a similar survey of deer in Wales.
MATERIALS AND METHODS
The deer survey. The survey focused on areas of high bTB prevalence in cattle
in the United Kingdom and was designed for a 95% certainty of detecting disease
at a prevalence of 5% (20). Running between December 2006 and February
2008, the survey aimed to sample 700 deer across 10 sites in the southwestern
peninsula and the Cotswolds; for this study, additional samples were obtained
from the Wales deer survey (22) between November 2007 and January 2008
inclusive.
In the southwestern peninsula, samples were obtained from all areas of the
public forest estate (Forestry Commission land) in Somerset, Devon, and Corn-
wall. In the Cotswolds, deer were sampled from three large private estates: the
Barnsley Wold deer management area (32 km2), Chedworth (143 km2), and the
Cirencester Park area (253 km2). In Wales, deer were sampled from Forestry
Commission land in the Lower Wye Valley forest district and the Coed-y-
Cymoedd forest district. These areas were selected based on the high frequency
of cattle herd breakdowns and a high prevalence of bTB in badgers.
Tissue sampling. All deer shot for routine management and sporting purposes
during each species’ open season were sampled. All carcasses were subjected to
a routine postmortem meat inspection as required by European Union food
hygiene regulations. Stalkers and Forestry Commission officials were trained and
instructed to collect tissues by a standard protocol, thereby ensuring that all
postmortems were performed to the same standard; the stalkers’ knowledge was
valuable, as it enabled them to better detect the lesions. Tissues were collected
at the time of carcass inspection or gutting (removal of offal), and a maximum of
20 g of tissue from each individual was submitted. From carcasses with visible
lesions (VL) typical of bTB infection, the two most characteristic lesions with a
small circumference of normal tissue were submitted, for a total of no more than
20 g of tissue. Samples from deer with no VL (classified as those with no VL or
lesions atypical of bTB) comprised a predefined list of lymph node tissue sam-
ples: paired bronchial samples, mediastinal samples, paired retropharyngeal
samples, a sample of mesenteric lymph nodes, and samples of any other abnor-
mal lymph nodes. Other lymph nodes, known to harbor bTB lesions, were only
included if they looked abnormal, i.e., paired prescapular, supramammary, he-
patic, and head nodes other than the retropharyngeal nodes.
Culture of M. bovis from tissue samples. Tissue samples were submitted by
first class mail to the TB Diagnostics Department of the Veterinary Laboratories
Agency at Weybridge. Tissues were trimmed of fat, any VL were described, and
then the tissues were ground in a stomacher with 15 ml 0.85% saline. The tissue
was decontaminated with 15 ml 10% oxalic acid and washed in 30 ml 0.85%
physiological saline, and then 0.3 ml of inoculum preparation was sown onto the
following solid-medium slopes: three slopes each of Stonebrinks medium, mod-
ified 7H11 medium, and Dubos medium with or without mycobactin and two
slopes each of Lowenstein-Jensen (LJ) medium base, LJ medium base with
pyruvate, and LJ medium base with glycerol. The remaining inoculum was frozen
for reculture and utilized after being retreated with oxalic acid if more than one
of the LJ medium base or 7H11 medium cultures were contaminated. Single
liquid cultures were prepared with 3 and 10 ml of 7H9 medium and double-
strength Dubos broth, respectively, both contained in screw-cap glass vials. The
slopes were read after 6 weeks of incubation at 37°C. In cases with no evidence
of growth on the solid medium, a Ziehl-Neelsen stain was made from both types
of Dubos medium, and if it was clear of acid-fast bacteria, the sample was
declared negative. Any growths characteristic of mycobacteria or any identified
as acid-fast bacteria were identified as M. bovis by spoligotyping (11, 12).
Blood collection and processing. Samplers were instructed to collect fresh
nonclotted blood from the heart or jugular vein as soon as possible after death.
Blood from each individual was collected into one 8.5-ml SST Vacutainer tube
(BD, Plymouth, United Kingdom) which was submitted, by post, with the indi-
vidual’s tissue samples. In order to avoid a prolonged time in transit, samples
were not posted on Fridays, Saturdays, or Bank Holidays but stored in approved
larder chillers (4 to 6°C) until the next working day. Upon receipt, the blood
tubes were stored between 4 and 8°C for a maximum of 8 h, after which the blood
was centrifuged and the serum tested. Some serum samples had to be frozen
prior to testing, but unless a test had to be repeated, no serum samples went
through more than one freeze-thaw cycle prior to testing. Serum samples were
stored frozen at 80°C. Blood sample quality was assessed by subjective scoring
of the degree of hemolysis and a record of the length of time spent in transit.
Samples with no visible hemolysis were given a score of 0; the maximum hemo-
lysis score was 4 for highly hemolyzed and/or decomposed samples, all of which
were tested. The length of time spent in transit was calculated as the time
between slaughter and sample receipt.
CervidTB STAT-PAK. The serum samples were tested according to the man-
ufacturer’s instructions. Briefly, 30 l of serum was added to the test strip,
followed by 3 drops of diluent; the results were read visually after 20 min. The
test results were only considered valid if a blue band was visible in the control
area of the test strip. If a blue band also developed in the test area, the sample
was considered antibody positive; if the test area remained clear, the sample was
considered antibody negative. Any tests which failed to develop a line in the
control area were repeated with a new kit.
Statistical analyses. The correlation between the time spent in transit and the
degree of hemolysis was tested with the Spearman rank analysis tool of the
GraphPad Prism 5.02 software (GraphPad Software, Inc., La Jolla, CA).
The Fisher exact test analysis tool of the same software was utilized to test for a
difference in the sensitivity of STAT-PAK as applied to good (low hemolysis
score)- and poor (high hemolysis score)-quality samples. In both analyses, sig-
nificance was taken as a P value of 0.05.
RESULTS
Prevalence of M. bovis and characterization of serum sam-
ples. A total of 860 deer were tissue sampled for the culture of
M. bovis; not all of the 860 deer could be STAT-PAK tested, as
blood sampling was initiated 4 months after the start of the
survey. For the STAT-PAK evaluation, 439 (86.1%) of the 512
tissue samples submitted during this evaluation were accom-
panied by blood samples. Of the 439 samples received, 7
(1.6%) failed to yield any serum and therefore 432 deer were
tested for M. bovis infection by both STAT-PAK and tissue
culture. The culture prevalence of the survey as a whole was
low (3.8%, n  860), and only 1.6% (n  432) of the deer used
in the STAT-PAK evaluation were culture positive.
The blood samples showed a great variation in quality, as
indicated by the degree of hemolysis (Fig. 1a), and spent up to
10 days (in storage and) in transit (Fig. 1b). More than half
(57%) of the serum samples spent longer than 3 days in transit,
and 87% (n  432) were classed as hemolyzed (scores of 1 to
4); there was a weak association between the time spent in
transit and the degree of hemolysis (Spearman rank, R  0.62,
P  0.048). Nonetheless, antibodies to M. bovis were detected
not only in good-quality serum samples but also in hemolyzed
samples from culture-positive deer which had not been sepa-
rated for as long as 6 days postslaughter.
CervidTB STAT-PAK performance. In this study, estimates
of the sensitivity and positive predictive value (PPV; Table 1)
of STAT-PAK had broad confidence intervals (CIs), as the
prevalence of M. bovis was low. The proportion of positive
STAT-PAK results (28/432, 6.5%) was higher than the culture
prevalence (7/432, 1.6%) for each species (Fig. 2). Of the 7
culture-positive deer that were STAT-PAK tested, 6 (85.7%)
were STAT-PAK reactive; of the 425 culture-negative deer,
403 (94.8%) were STAT-PAK nonreactive (Table 2). The odds
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ratio was 109.9 (95% CI, 12.7 to 953.6) for a positive STAT-
PAK result among culture-confirmed cases. In other words,
culture-positive deer were 110 times more likely to yield a
positive STAT-PAK result than were culture-negative deer.
The condition of the samples has been shown to negatively
affect the sensitivity of STAT-PAK for the detection of bTB in
badgers (3), but it was not possible to detect such an effect in
this study (Fisher exact test, P  0.05). Only two (0.5%) of the
STAT-PAK tests failed to produce a line in the control section
of the strip, and these culture-negative samples were retested
and were both STAT-PAK negative.
DISCUSSION
The performance of the CervidTB STAT-PAK on United
Kingdom deer (Table 1) compared well to a previous evalua-
tion with white-tailed deer (Odocoileus virginianus) in the
United States in which the sensitivity, specificity, and accuracy
were 75.0% (95% CI, 54.8 to 88.6%), 98.9% (95% CI, 97.2 to
99.6%), and 97.4% (95% CI, 95.4 to 98.6%), respectively (13).
The CervidTB STAT-PAK performed similarly well (sensitiv-
ity, 73%; specificity, 100%) with experimentally infected C.
elaphus (10). However, comparisons between different deer
species must be interpreted with caution, as different species
vary in susceptibility to bTB (16) and experimentally infected
animals may yield a higher test sensitivity than naturally in-
fected free-ranging animals (13).
Although the CervidTB STAT-PAK was sensitive, the low
prevalence of bTB among deer in this survey resulted in a low
PPV and broad CIs for the sensitivity estimate (85.7%, 42.1 to
99.6%). Only a small subset of all culture-positive deer were
STAT-PAK tested (7/33 culture positives out of 860 deer sam-
pled in the survey as a whole). This is, in part, due to the fact
that the blood sampling started 4 months after the survey
started and because samplers failed to collect blood from 73
animals. This meant that five additional culture-positive deer
could not be STAT-PAK tested. A lower sensitivity has also
been observed elsewhere for this assay (19), and this has im-
plications for the use of the test on United Kingdom deer if
further evaluations on the United Kingdom deer species again
result in a low sensitivity estimate.
A relatively high proportion of positive CervidTB STAT-
PAK results remained unconfirmed by culture, as STAT-PAK
positivity was higher than the culture prevalence and more
than 70% of the STAT-PAK-positive deer were culture nega-
tive. This may be due to the fact that culture underestimates
the true prevalence of infection. The probability of isolating M.
bovis by culture is higher for samples taken from a whole (and
thoroughly inspected) carcass than it is from gutting alone (5).
Culture from selected lymph nodes may not be sensitive
enough to detect those with very low-grade infections. How-
ever, the prevalence estimate for the southwest in the most
TABLE 1. Performance of CervidTB STAT-PAK
Parametera Value (%) 95% CI
Sensitivity 85.7 42.1–99.6
Specificity 94.8 92.3–96.7
Accuracy 94.7 92.1–96.6
PPV 21.4 8.3–41.0
NPV 99.8 98.6–100.0
a The accuracy is the percentage of STAT-PAK results which were in agree-
ment with bTB culture results. NPV, negative predictive value. n  432.
FIG. 1. Distribution of STAT-PAK-positive deer across the sam-
ples’ hemolysis scores (a) and the times samples spent in transit (b).
n  432.
FIG. 2. Prevalence of M. bovis in the different deer species as de-
termined by culture and STAT-PAK.
TABLE 2. Numbers of deer positive and negative by STAT-PAK
and culturea
STAT-PAK
result
No of cultures
Total
Positive Negative
Positive 6 22 28
Negative 1 403 404
Total 7 425 432
a Culture-positive deer were those positive for M. bovis, while culture-negative
deer included those positive for M. avium and other, unclassified, mycobacteria.
Of those culture negative for M. bovis (n  425), 6 were positive for M. avium and
2 for unclassified mycobacteria. STAT-PAK was specific, as only one of the M.
avium-positive deer was STAT-PAK positive.
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recent survey (3.4%, 22/655; 95% CI, 2.1 to 5.4%) (20) was
similar to that of a previous survey of the same region (2.2%,
36/1646; 95% CI, 1.5 to 3.0%) which utilized more-thorough
sampling techniques (5).
In this study, the CervidTB STAT-PAK showed a relatively
low proportion of false positives (5.2%). A previous evaluation
of this test with serum samples from animals infected with
non-TB mycobacteria found no cross-reactions (13), and a
specificity of 95% was also reported for badgers (8). In the
present study, only one individual was STAT-PAK positive and
M. avium culture positive, and it is possible that the serological
response of this individual was due to a cryptic M. bovis infec-
tion or recovery from an M. bovis infection while still seropos-
itive. In contrast, a recent evaluation of the CervidTB STAT-
PAK in New Zealand demonstrated a lower specificity (83.8%)
due to a partial cross-reactivity of the assay in deer infected
with Johne’s disease (B. Buddle, unpublished data); the prev-
alence of Johne’s disease in United Kingdom deer is largely
unknown.
In conclusion, this study showed the CervidTB STAT-PAK
to be a potentially sensitive and practical assay for the detec-
tion of M. bovis infection in deer in Great Britain. It would be
advantageous to deploy this test in the field for additional
validation with fresh whole-blood samples to improve the con-
fidence of the sensitivity estimate by eliminating postal delays
and improving the quality of the blood samples tested.
ACKNOWLEDGMENTS
We thank the staff of the Veterinary Laboratories Agency TB Di-
agnostic Department for their help with the samples and culture data.
We also thank C. Griffiths of the Welsh Assembly Government’s De-
partment for Rural Affairs for her assistance in obtaining deer samples
and S. Palmer and R. Ashford for their assistance with the sample
processing.
REFERENCES
1. Anonymous. 1997. Bovine tuberculosis in badgers. MAFF Publications, Lon-
don, United Kingdom.
2. Buddle, B. M., M. A. Skinner, and M. A. Chambers. 2000. Immunological
approaches to the control of tuberculosis in wildlife reservoirs. Vet. Immu-
nol. Immunopathol. 74:1–16.
3. Chambers, M. A., T. Crawshaw, S. Waterhouse, R. Delahay, R. G. Hewinson,
and K. P. Lyashchenko. 2008. Validation of the BrockTB Stat-Pak assay for
detection of tuberculosis in Eurasian badgers (Meles meles) and influence of
disease severity on diagnostic accuracy. J. Clin. Microbiol. 46:1498–1500.
4. Delahay, R. J., C. L. Cheeseman, and R. S. Clifton-Hadley. 2001. Wildlife
disease reservoirs: the epidemiology of Mycobacterium bovis infection in the
European badger (Meles meles) and other British mammals. Tuberculosis
(Edinburgh) 81:43–49.
5. Delahay, R. J., G. C. Smith, A. M. Barlow, N. Walker, A. Harris, R. S.
Clifton-Hadley, and C. L. Cheeseman. 2007. Bovine tuberculosis infection in
wild mammals in the South-West region of England: a survey of prevalence
and a semi-quantitative assessment of the relative risks to cattle. Vet. J.
173:287–301.
6. Department for Environment, Food, and Rural Affairs. 28 November 2008.
Wild deer and bovine TB. Department for Environment, Food, and Rural
Affairs, London, United Kingdom. http://www.defra.gov.uk/news/2008/081126b
.htm.
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